Hino S, Doi H, Yoshikuni H, Sugiyama H, Ishimaru T, Yamabe T, Tsuji Y, Miyamoto T
Department of Bacteriology, Nagasaki University School of Medicine.
Jpn J Cancer Res. 1987 Nov;78(11):1156-8.
High-titer antibody against HTLV-I in carrier mothers is proposed as a secondary parameter for risk of viral transmission to the children via milk. For titration of antibodies, a less expensive modified gelatin particle agglutination assay (approximately 40% of the standard cost) was developed. None of 11 carrier mothers with antibody titers of less than 4000 had carrier children, whereas 11 out of 17 mothers with titers of 256,000 or higher had carrier children. The antibody titer was correlated with antigen-bearing cells detectable in cultures of peripheral blood T-lymphocytes, which was previously described as a marker of risk for transferring HTLV-I to children.
携带HTLV-I的母亲体内的高滴度抗体被认为是通过乳汁将病毒传播给孩子风险的一个次要参数。为了进行抗体滴定,开发了一种成本较低的改良明胶颗粒凝集试验(约为标准成本的40%)。11名抗体滴度低于4000的携带病毒母亲所生子女均未携带病毒,而17名滴度为256,000或更高的母亲中有11名所生子女携带病毒。抗体滴度与在外周血T淋巴细胞培养物中可检测到的携带抗原的细胞相关,外周血T淋巴细胞培养物中可检测到的携带抗原的细胞此前被描述为将HTLV-I传播给儿童的风险标志物。